Exploring PrP <sup>C</sup> unfolding as a critical step preceding its refolding in the context of PrP <sup>Sc</sup> propagation

S Sanaz Sabzehei (Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago) M Marta Rigoli (Department of Cellular, Computational and Integrative Biology, University of Trento) R Raúl Cacheiro (Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago) I Iria Díaz-Arias (Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago) H Hasier Eraña (Asociación Centro de Investigación Cooperativa en Biociencias, Basque Research and Technology Alliance, Prion Research Lab) R Rubén P. Lago (Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago) A Arcadio Guerra (Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela) H Human Rezaei (Université Paris-Saclay, Institut National de Recherche pour l‘Agriculture, l‘Alimentation et l‘Environnement, Université Versailles-Saint Quentin, Unité de Virologie et d‘Immunologie Moléculaires) J Joaquín Castilla (Asociación Centro de Investigación Cooperativa en Biociencias, Basque Research and Technology Alliance, Prion Research Lab) E Emiliano Biasini (Department of Cellular, Computational and Integrative Biology, University of Trento) V Víctor M. Sánchez-Pedregal (Department of Organic Chemistry, University of Santiago de Compostela) M Manuel Martín-Pastor (Unidade de Resonancia Magnética, University of Santiago de Compostela) J Jesús R. Requena (Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago)

Abstract

It might have been believed that elucidation of the atomistic structure of PrP Sc would lead to an immediate understanding of the mechanism of prion propagation. However, PrP Sc , now known to be a “simple” amyloid, can only template a previously unfolded polypeptide chain. Therefore, PrP Sc can easily template the disordered ~90–120 domain of an incoming PrP C molecule, but not its ~121–231 folded domain (FD). The FD needs to accommodate into the ~121–230 PrP Sc surface, an inert “procrustean bed”. Thus, a mechanism for concerted unfolding/refolding of the FD must exist, with FD unfolding as a key element. To explore how this might happen, we performed thermal unfolding of recombinant bank vole PrP C (90–231), a universal PrP Sc propagator, tracking changes at the residue level with solution NMR to pinpoint early unfolding propensity. Our data suggest that a key early event is the destabilization of the short β1-β2 assembly and that the segment contiguous to the disordered tail, ~121–140, encompassing β1 and its adjacent coils, is the most likely region to unfold first. Spectroscopic data obtained at higher temperatures suggest that portions of alpha helix α2 are likely the last elements of the FD to unfold and refold into the PrP Sc conformation. Molecular Dynamics simulations assisted the interpretation of these changes and suggest separation of α1 from the rest of the FD ensemble. Our data provide a conceivable timeline of the early events in PrP Sc -assisted conversion of PrP C and should serve as a starting framework to develop a future atomistic model of PrP Sc propagation.

Article Details

Volume / Issue Vol. 123, Issue 18
Published May 05, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

S

Sanaz Sabzehei

Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago

M

Marta Rigoli

Department of Cellular, Computational and Integrative Biology, University of Trento

R

Raúl Cacheiro

Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago

I

Iria Díaz-Arias

Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago

H

Hasier Eraña

Asociación Centro de Investigación Cooperativa en Biociencias, Basque Research and Technology Alliance, Prion Research Lab

R

Rubén P. Lago

Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago

A

Arcadio Guerra

Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela

H

Human Rezaei

Université Paris-Saclay, Institut National de Recherche pour l‘Agriculture, l‘Alimentation et l‘Environnement, Université Versailles-Saint Quentin, Unité de Virologie et d‘Immunologie Moléculaires

J

Joaquín Castilla

Asociación Centro de Investigación Cooperativa en Biociencias, Basque Research and Technology Alliance, Prion Research Lab

E

Emiliano Biasini

Department of Cellular, Computational and Integrative Biology, University of Trento

V

Víctor M. Sánchez-Pedregal

Department of Organic Chemistry, University of Santiago de Compostela

M

Manuel Martín-Pastor

Unidade de Resonancia Magnética, University of Santiago de Compostela

J

Jesús R. Requena

Center for Research in Molecular Medicine and Chronic Diseases and Department of Medical Sciences, University of Santiago de Compostela-Instituto de Investigación Sanitaria de Santiago